|
Conesa-Zamora P, Ruiz-Cosano J, Torres-Moreno D, Español I, Gutiérrez-Meca MD, Trujillo-Santos J, Pérez-Ceballos E, González-Conejero R, Corral J, Vicente V, Pérez-Guillermo M. Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study. BMC Cancer. 2013 May 7;13:228. doi: 10.1186/1471-2407-13-228. PubMed PMID: 23651475; PubMed Central PMCID: PMC3649938.
AÑO: 2013; IF: 3.319
|
23651475
|
Anton AI, Cerezo-Manchado JJ, Padilla J, Perez-Andreu V, Corral J, Vicente V, Roldan V, Gonzalez-Conejero R. Novel associations of VKORC1 variants with higher acenocoumarol requirements. PLoS One. 2013 May 17;8(5):e64469. doi: 10.1371/journal.pone.0064469. PubMed PMID: 23691226; PubMed Central PMCID: PMC3656883.
AÑO: 2013; IF: 3.534
|
|
Teruel R, Martínez-Martínez I, Guerrero JA, González-Conejero R, de la Morena-Barrio ME, Salloum-Asfar S, Arroyo AB, Águila S, García-Barberá N, Miñano A, Vicente V, Corral J, Martínez C. Control of post-translational modifications in antithrombin during murine post-natal development by miR-200a. J Biomed Sci. 2013 May 16;20:29. doi: 10.1186/1423-0127-20-29. PubMed PMID: 23678987; PubMed Central PMCID: PMC3674942.
AÑO: 2013; IF: 2.736
|
|
Cerezo-Manchado JJ, Rosafalco M, Antón AI, Pérez-Andreu V, Garcia-Barberá N, Martinez AB, Corral J, Vicente V, González-Conejero R, Roldán V. Creating a genotype-based dosing algorithm for acenocoumarol steady dose. Thromb Haemost. 2013 Jan;109(1):146-53. doi: 10.1160/TH12-08-0631. PubMed PMID: 23196355.
AÑO: 2013; IF: 5.76
|
|
Pérez-Andreu V, Teruel R, Corral J, Roldán V, García-Barberá N, Salloum-Asfar S, Gómez-Lechón MJ, Bourgeois S, Deloukas P, Wadelius M, Vicente V, González-Conejero R, Martínez C. miR-133a regulates vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the vitamin K cycle. Mol Med. 2013 Jan 22;18:1466-72. doi: 10.2119/molmed.2012.00062. PubMed PMID: 23154637; PubMed Central PMCID: PMC3563709.
AÑO: 2012; IF: 4.469
|